Stephen Waxman, MD, PhD, Yale University, New Haven, US, discusses his studies of rare painful diseases, which have lessons for understanding pain more broadly, advice for trainees as they develop their careers in pain research, and why he thinks it's important to communicate research to the public.

Amanda Brandow, DO, and Kate Sadler, PhD, both from the Medical College of Wisconsin, discuss sickle cell pain, how they are collaborating to help increase understanding of this condition, and much more.

Jeffrey Mogil, PhD, McGill University, Montreal, Canada, discusses how he came to study sex differences in pain, why those differences matter, and why he now considers himself more as a "meta-scientist" rather than as a pain researcher.

Tor Wager, PhD, Dartmouth College, US, discusses all things placebo, including what brain imaging has revealed about placebo analgesia, the role of prior experience and expectations in the placebo response, and much more.

2018 North American Pain School patient partners Leslie Levine and Jacques Laliberté speak about their experiences with chronic pain, their advocacy efforts, and the importance of including patients as partners in pain research.

Kathleen Sluka, PhD, University of Iowa, Iowa City, US, discusses her path to pain research, why she thinks it's time for the field to move on from efficacy studies of exercise for pain, and her love of painting.

Robert Gereau, PhD, Washington University School of Medicine in St. Louis, US, discusses his use of human tissue in pain research, optogenetics, and science advocacy, among other topics.

Irene Tracey, PhD, University of Oxford, UK, talks about pain brain (and spinal cord) imaging, why she thinks it's time to rebrand or rename the term "placebo analgesia," and her advice for young scientists.

Ian Gilron, MD, Queen's University School of Medicine, Canada, discusses his work on clinical trials of treatments for chronic pain, combination therapy, and much more.